Physician profile
Lori Wright
NPI 1639669088
$4,859.96
in general payments reported to CMS, 2019-2025
60 companies · $1,681 in 2025
The $1,681 reported for 2025 was more than what 92% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $665 · 2022: $319 · 2023: $923 · 2024: $1,272 · 2025: $1,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,653 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,652.73 |
| Education | $223.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $365.02 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $355.12 | 2023-2025 | Opdivo, Opdualag, Krazati |
| Merck Sharp & Dohme LLC | $335.66 | 2021-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Celgene Corporation | $258.80 | 2023-2025 | Pomalyst, Reblozyl |
| Astrazeneca Pharmaceuticals Lp | $197.76 | 2021-2025 | Enhertu, Lynparza, Calquence |
| Glaxosmithkline, LLC. | $196.10 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Abbvie INC. | $193.61 | 2021-2025 | |
| Daiichi Sankyo INC. | $181.72 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Adaptive Biotechnologies Corporation | $181.47 | 2022 | |
| Lilly USA, LLC | $166.62 | 2021-2024 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $148.42 | 2023-2025 | Darzalex, Rybrevant, Tecvayli |
| Incyte Corporation | $146.06 | 2023 | Jakafi, Monjuvi, Pemazyre |
| Seagen INC. | $133.18 | 2022-2025 | Adcetris |
| Novocure INC. | $124.76 | 2023-2024 | Optune, Optune Lua (Novottf-200t) |
| Genentech USA, INC. | $100.10 | 2023-2025 | Venclexta |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.